Department of Neurosurgery, University of Michigan, 1500 E. Medical Center Drive, 3552 Taubman Health Care Center, SPC 5338, Ann Arbor, MI, 48109, USA.
Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
Neurocrit Care. 2020 Oct;33(2):597-603. doi: 10.1007/s12028-020-01068-1. Epub 2020 Aug 7.
Many COVID-19 patients with neurological manifestations and respiratory failure remain dependent on mechanical ventilation and require tracheostomy, which is an aerosol generating procedure (AGP). The risk of SARS-CoV-2 transmission to healthcare staff during AGPs is well documented, and negative-pressure rooms are often unavailable. Innovative techniques to decrease risk to healthcare providers during AGPs are necessary. Our objective was to demonstrate the feasibility of percutaneous dilatational tracheostomy (PDT) performed using a novel prefabricated low-cost negative-pressure tent (AerosolVE).
Retrospective review of consecutive PDT procedures performed by neurointensivists on intubated adult patients with COVID-19 using the AerosolVE tent during the pandemic under an innovative clinical care protocol. The AerosolVE negative-pressure tent consists of a clear plastic canopy with slits for hand access attached to a U-shaped base with air vents. Air within the tent is drawn through a high-efficiency particulate air filter and released outside. Preliminary testing during simulated AGPs demonstrated negligible escape of particulate matter beyond the tent. The main outcome measure was successful completion of PDT and bronchoscopy within the AerosolVE tent, without complications.
The patients were a 53-year-old man with multifocal ischemic stroke and acute respiratory distress syndrome (ARDS), 53-year-old woman with cerebellar hemorrhage and ARDS, and a 69-year-old man with ARDS. Pre-procedure FiO requirement was 40-50% and positive end-expiratory pressure (PEEP) 8-12 cm HO. The tent was successfully positioned around the patient and PDT completed with real-time ultrasound guidance in all 3 patients. Bronchoscopy was performed to confirm tube position and perform pulmonary toilet. No complications occurred.
It is feasible to perform PDT on intubated COVID-19 patients using the AerosolVE negative-pressure tent. This is a promising low-cost device to decrease risk to healthcare providers during AGPs.
许多出现神经系统表现和呼吸衰竭的 COVID-19 患者仍依赖于机械通气并需要进行气管切开术,这是一种气溶胶产生程序(AGP)。在 AGP 期间,SARS-CoV-2 向医护人员传播的风险已有充分记录,且负压室通常不可用。因此,有必要采用创新技术来降低 AGP 期间医护人员的风险。我们的目的是展示在大流行期间,使用新型预制低成本负压帐篷(AerosolVE)进行经皮扩张气管切开术(PDT)的可行性。
对神经重症监护医生在大流行期间使用 AerosolVE 帐篷根据一项创新的临床护理方案对 COVID-19 气管插管的成年患者进行 PDT 操作的连续 PDT 程序进行回顾性审查。AerosolVE 负压帐篷由带有用于手部进入的狭缝的透明塑料罩组成,连接到带有通风口的 U 形底座。帐篷内的空气通过高效微粒空气过滤器吸入并释放到外部。在模拟 AGP 期间进行的初步测试表明,帐篷内的颗粒物几乎没有逸出。主要观察指标是在 AerosolVE 帐篷内成功完成 PDT 和支气管镜检查,无并发症。
患者为 53 岁男性,患有多灶性缺血性中风和急性呼吸窘迫综合征(ARDS);53 岁女性,患有小脑出血和 ARDS;69 岁男性,患有 ARDS。术前 FiO 要求为 40-50%,呼气末正压(PEEP)为 8-12cmH2O。该帐篷成功定位在患者周围,在所有 3 名患者中均使用实时超声引导完成 PDT。进行支气管镜检查以确认导管位置并进行肺部清理。未发生并发症。
使用 AerosolVE 负压帐篷对 COVID-19 气管插管患者进行 PDT 是可行的。这是一种有前途的低成本设备,可降低 AGP 期间医护人员的风险。